Navigation Links
Awards celebrate clinical research that can improve health and alleviate suffering
Date:4/18/2012

WASHINGTON Ten outstanding clinical research projects from institutions around the country have been selected to receive the inaugural Clinical Research Forum Top 10 Clinical Research Achievement Awards. The winning projects are compelling examples of the scientific innovation that results from the nation's investment in clinical research that can benefit human health and welfare.

Awardees hail from Baylor College of Medicine, the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Duke University, Seattle Children's Research Institute/the University of Washington, the University of Cincinnati, the University of Colorado School of Medicine, the University of North Carolina at Chapel Hill, the University of Pennsylvania and the Ragon Institute of MGH, MIT and Harvard.

"There's never been a moment that's more optimistic in the history of biology for spectacular breakthroughs to happen, but it will require strategic investment at a most difficult time in our history," said William F. Crowley Jr., M.D., founder and past chairman of the Clinical Research Forum and director of the Clinical Research Program at Massachusetts General Hospital. "But that is what has made America the world leader in biomedical research, and if we're going to retain that we have to continue making these investments."

All published within the last two years, the studies are the latest in a long tradition of notable health advances such as eliminating polio and improving cancer survival rates that were propelled by combined investment in basic science and clinical research. Collectively, the work was funded by a range of federal agencies including the National Institutes of Health, the National Science Foundation and the Food and Drug Administration, as well as many foundations and corporations.

"Clinical research is key to our efforts to turn discoveries into health, serving as the bridge between advances in basic scientific understanding and the development of new ways to diagnose, treat, and prevent disease," said NIH Director Francis S. Collins, M.D., Ph.D. "NIH is a major supporter of clinical research and I am delighted to see this important field get the recognition it so richly deserves."

The projects, which tackled difficult health problems and required extensive collaboration, are remarkable for their bold approaches, innovation and potential for alleviating human suffering. In the area of disease prevention, the winning research has made an impact through prevention of complications after bone marrow transplantation, stroke and potentially fatal bacterial infection of implanted medical devices. New therapies were developed for cystic fibrosis, a chronic form of leukemia and a rare lung condition. And new methods were derived for identifying immune system targets of anti-HIV therapies, reducing HIV transmission through early treatment and identifying risk factors for cardiovascular disease.

The top prize was awarded for findings that early treatment with medications can prevent HIV transmission. This provides solid support for global public health policies on HIV and could help save millions of lives. The work was honored with the Herbert Pardes Clinical Research Excellence Award, named for the former president and chief executive officer of New York-Presbyterian Hospital, a physician who is regarded as a champion and visionary in clinical research.

"The tripartite mission of excellence in research, medical education and patient care unites all scientists in academic medical settings in their pursuit of clinical research that will expand the boundaries of medicine, increase the ability to diagnose, treat and prevent disease, and offer patients and their families hope for the future," Pardes said. "I am delighted to be able to advance this vitally important mission and support clinical researchers as they pursue game-changing medical breakthroughs."

Two distinguished clinical research achievement awards went to efforts to prevent complications after bone marrow transplants by temporarily disabling the body's defense mechanisms, and to a novel method for killing leukemic cells in patients who have exhausted all other treatment options. This work and all the others help inform future medical practice, open new lines of attack against disease and reduce the burden of sickness and premature death.

The studies were published in The New England Journal of Medicine, Nature and the Proceedings of the National Academy of Sciences. Winning researchers were honored April 18 during the Clinical Research Forum annual meeting and awards dinner in Washington, D.C., where they also presented their work.


'/>"/>

Contact: Cherri McGrew
cherrimcgrew@me.com
202-775-0554
Clinical Research Forum
Source:Eurekalert

Related medicine news :

1. Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards
2. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
3. International Diabetes Federation awards $2 million to 9 global diabetes research projects
4. Highmark Foundation Awards $120,000 to the American Heart Association
5. Diane von Furstenberg Establishes The DVF Awards to Recognize Outstanding Women Leaders
6. Siemens Awards for Advanced Placement Honor Top U.S. Science and Math Students and Teachers
7. Awards Strengthen Stonhard's Reputation for High-Performing Floors in the World's Most Prominent Pharmaceutical Facilities
8. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
9. AADR awards the 2010 Distinguished Mentoring Award to Irwin D. Mandel
10. AADR awards the 2010 AADR William B. Clark Fellowship to Isabel Gay
11. AADR awards the 2010 Distinguished Scientist Award to John Greenspan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... analytics to its patient care management module. Using this new feature, sleep physicians ... has been initiated on continuous positive airway pressure (CPAP), oral, or other forms ...
(Date:4/25/2017)... ... ... There is no better place in South Florida to undergo two common heart ... of Consumer Reports focused on heart health. , The magazine gave Memorial ... bypass and aortic valve replacement procedures. , Consumer Reports rated Memorial’s Cardiac ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., ... of its strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), ... and effective management of complex spine deformity cases, particularly in children. , GSO’s ...
(Date:4/24/2017)... ORLANDO, FLORIDA (PRWEB) , ... April 24, 2017 ... ... of telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth ... compliment LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed ...
(Date:4/24/2017)... , ... April 24, 2017 , ... The Santana Telehealth ... ATA 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on April 23 ... Project for using telemedicine to improve the lives of the poor and underserved in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
Breaking Medicine Technology: